Search

Your search keyword '"Bonow, Robert O"' showing total 2,525 results
Start Over Author "Bonow, Robert O"

Refine your results

more »

more »

more »

more »

more »
2,525 results on '"Bonow, Robert O"'

6. 2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures

Author

Jneid, Hani, Chikwe, Joanna, Arnold, Suzanne V., Bonow, Robert O., Bradley, Steven M., Chen, Edward P., Diekemper, Rebecca L., Fugar, Setri, Johnston, Douglas R., Kumbhani, Dharam J., Mehran, Roxana, Misra, Arunima, Patel, Manesh R., Sweis, Ranya N., and Szerlip, Molly

Published
2024
Full Text
View/download PDF

7. Foreword

Author

Braunwald, Eugene, primary, Libby, Peter, additional, Bonow, Robert O., additional, Mann, Douglas L., additional, Tomaselli, Gordon F, additional, Bhatt, Deepak L., additional, and Solomon, Scott D., additional

Published
2023
Full Text
View/download PDF

9. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition

Author

Prabhakaran, Dorairaj, Anand, Shuchi, Watkins, David, Gaziano, Thomas, Wu, Yangfeng, Mbanya, Jean Claude, Nugent, Rachel, Ajay, Vamadevan S, Afshin, Ashkan, Adler, Alma, Ali, Mohammed K, Bateman, Eric, Bettger, Janet, Bonow, Robert O, Brouwer, Elizabeth, Bukhman, Gene, Bull, Fiona, Burney, Peter, Capewell, Simon, Chan, Juliana, Chandrasekar, Eeshwar K, Chen, Jie, Criqui, Michael H, Dirks, John, Dugani, Sagar B, Engelgau, Michael, Nahas, Meguid El, Fall, Caroline HD, Feigin, Valery, Fowkes, F Gerald R, Glassman, Amanda, Goenka, Shifalika, Gupta, Rajeev, Hasan, Babar, Hersch, Fred, Hu, Frank, Huffman, Mark D, Jabbour, Samer, Jarvis, Deborah, Jeemon, Panniyammakal, Joshi, Rohina, Kamano, Jemima H, Kengne, Andre Pascal, Kudesia, Preeti, Kumar, R Krishna, Kumaran, Kalyanaraman, Lambert, Estelle V, Lee, Edward S, Li, Chaoyun, Luo, Rong, Magee, Matthew, Malik, Vasanti S, Marin-Neto, J Antonio, Marks, Guy, Mayosi, Bongani, McGuire, Helen, Micha, Renata, Miranda, J Jaime, Montoya, Pablo Aschner, Moran, Andrew E, Mozaffarian, Dariush, Naicker, Saraladevi, Naidoo, Nadraj G, Narayan, KM Venkat, Nikolic, Irina, O'Donnell, Martin, Onen, Churchill, Osmond, Clive, Patel, Anushka, Perez-Padilla, Rogelio, Poulter, Neil, Pratt, Michael, Rabkin, Miriam, Rajan, Vikram, Rassi, Anis, Rawal, Ishita, Remuzzi, Giuseppe, Riella, Miguel, Roth, Greg A, Roy, Ambuj, Rubinstein, Adolfo, Sakuma, Yuna, Sampson, Uchechukwu KA, Siegel, Karen R, Sliwa, Karen, Suhrcke, Marc, Tandon, Nikhil, Thomas, Bernadette, Vaca, Claudia, Vedanthan, Rajesh, Verguet, Stéphane, Webb, Michael, Weber, Mary Beth, Whitsel, Laurie, Wong, Gary, Yan, Lijing L, Yancy, Clyde W, Zhang, Ping, and Zhao, Dong

Subjects
Biomedical and Clinical Sciences, Public Health, Health Sciences, Cardiovascular, Health Services, Clinical Research, Prevention, Good Health and Well Being, Cardiovascular Diseases, Developing Countries, Health Priorities, Humans, Respiratory Tract Diseases, Disease Control Priorities-3 Cardiovascular, Respiratory, and Related Disorders Author Group, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences
Abstract

Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide, and substantial inequalities in care of patients with CVRDs exist between countries of high income and countries of low and middle income. Based on current trends, the UN Sustainable Development Goal to reduce premature mortality due to CVRDs by a third by 2030 will be challenging for many countries of low and middle income. We did systematic literature reviews of effectiveness and cost-effectiveness to identify priority interventions. We summarise the key findings and present a costed essential package of interventions to reduce risk of and manage CVRDs. On a population level, we recommend tobacco taxation, bans on trans fats, and compulsory reduction of salt in manufactured food products. We suggest primary health services be strengthened through the establishment of locally endorsed guidelines and ensured availability of essential medications. The policy interventions and health service delivery package we suggest could serve as the cornerstone for the management of CVRDs, and afford substantial financial risk protection for vulnerable households. We estimate that full implementation of the essential package would cost an additional US$21 per person in the average low-income country and $24 in the average lower-middle-income country. The essential package we describe could be a starting place for low-income and middle-income countries developing universal health coverage packages. Interventions could be rolled out as disease burden demands and budgets allow. Our outlined interventions provide a pathway for countries attempting to convert the UN Sustainable Development Goal commitments into tangible action.

Published
2018

13. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Author

Otto, Catherine M., Nishimura, Rick A., Bonow, Robert O., Carabello, Blase A., Erwin, John P., III, Gentile, Federico, Jneid, Hani, Krieger, Eric V., Mack, Michael, McLeod, Christopher, O'Gara, Patrick T., Rigolin, Vera H., Sundt, Thoralf M., III, Thompson, Annemarie, Toly, Christopher, Beckman, Joshua A., Levine, Glenn N., Al-Khatib, Sana M., Armbruster, Anastasia, Birtcher, Kim K., Ciggaroa, Joaquin, Deswal, Anita, Dixon, Dave L., Fleisher, Lee A., de las Fuentes, Lisa, Goldberger, Zachary D., Gorenek, Bulent, Haynes, Norrisa, Hernandez, Adrian F., Hlatky, Mark A., Joglar, José A., Jones, W. Schuyler, Marine, Joseph E., Mark, Daniel, Palaniappan, Latha, Piano, Mariann R., Spatz, Erica S., Tamis-Holland, Jacqueline, Wijeysundera, Duminda N., and Woo, Y. Joseph

Published
2021
Full Text
View/download PDF

15. Extracellular Volume in Primary Mitral Regurgitation

Author

Kitkungvan, Danai, Yang, Eric Y., El Tallawi, Kinan C., Nagueh, Sherif F., Nabi, Faisal, Khan, Mohammad A., Nguyen, Duc T., Graviss, Edward A., Lawrie, Gerald M., Zoghbi, William A., Bonow, Robert O., Quinones, Miguel A., and Shah, Dipan J.

Published
2021
Full Text
View/download PDF

19. Myocardial ischemia: From disease to syndrome

Author

Marzilli, Mario, Crea, Filippo, Morrone, Doralisa, Bonow, Robert O., Brown, David L., Camici, Paolo G., Chilian, William M., DeMaria, Anthony, Guarini, Giacinta, Huqi, Alda, Merz, C. Noel Bairey, Pepine, Carl, Scali, Maria Chiara, Weintraub, William S., and Boden, William E.

Published
2020
Full Text
View/download PDF

21. 2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter mitral valve intervention: A joint report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons Endorsed by the Heart Failure Society of America

Author

Bonow, Robert O., O'Gara, Patrick T., Adams, David H., Badhwar, Vinay, Bavaria, Joseph E., Elmariah, Sammy, Hung, Judy W., Lindenfeld, JoAnn, Morris, Alanna, Satpathy, Ruby, Whisenant, Brian, and Woo, Y. Joseph

Published
2020
Full Text
View/download PDF

22. 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons

Author

Bonow, Robert O., O’Gara, Patrick T., Adams, David H., Badhwar, Vinay, Bavaria, Joseph E., Elmariah, Sammy, Hung, Judy W., Lindenfeld, JoAnn, Morris, Alanna, Satpathy, Ruby, Whisenant, Brian, and Woo, Y. Joseph

Published
2020
Full Text
View/download PDF

25. 2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease

Author

Jneid, Hani, primary, Chikwe, Joanna, additional, Arnold, Suzanne V., additional, Bonow, Robert O., additional, Bradley, Steven M., additional, Chen, Edward P., additional, Diekemper, Rebecca L., additional, Fugar, Setri, additional, Johnston, Douglas R., additional, Kumbhani, Dharam J., additional, Mehran, Roxana, additional, Misra, Arunima, additional, Patel, Manesh R., additional, Sweis, Ranya N., additional, and Szerlip, Molly, additional

Published
2024
Full Text
View/download PDF

26. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.

Author

Ahmed, Amiya A, Patel, Kanan, Nyaku, Margaret A, Kheirbek, Raya E, Bittner, Vera, Fonarow, Gregg C, Filippatos, Gerasimos S, Morgan, Charity J, Aban, Inmaculada B, Mujib, Marjan, Desai, Ravi V, Allman, Richard M, White, Michel, Deedwania, Prakash, Howard, George, Bonow, Robert O, Fletcher, Ross D, Aronow, Wilbert S, and Ahmed, Ali

Subjects
Humans, Prognosis, Incidence, Multivariate Analysis, Proportional Hazards Models, Risk Assessment, Risk Factors, Chi-Square Distribution, Prospective Studies, Smoking, Smoking Cessation, Time Factors, Aged, Aged, 80 and over, United States, Female, Male, Heart Failure, Smoking Prevention, heart failure, mortality, smoking, Heart Disease, Tobacco Smoke and Health, Tobacco, Aging, Cardiovascular, Clinical Research, Prevention, Respiratory, Good Health and Well Being, Biochemistry and Cell Biology, Cardiorespiratory Medicine and Haematology, Medical Physiology, Cardiovascular System & Hematology
Abstract

BackgroundAccording to the 2004 Surgeon General's Report on Health Consequences of Smoking, after >15 years of abstinence, the cardiovascular risk of former smokers becomes similar to that of never-smokers. Whether this health benefit of smoking cessation varies by amount and duration of prior smoking remains unclear.Methods and resultsOf the 4482 adults ≥65 years without prevalent heart failure (HF) in the Cardiovascular Health Study, 2556 were never-smokers, 629 current smokers, and 1297 former smokers with >15 years of cessation, of whom 312 were heavy smokers (highest quartile; ≥32 pack-years). Age-sex-race-adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for centrally adjudicated incident HF and mortality during 13 years of follow-up were estimated using Cox regression models. Compared with never-smokers, former smokers as a group had similar risk for incident HF (aHR, 0.99; 95% CI, 0.85-1.16) and all-cause mortality (aHR, 1.08; 95% CI, 0.96-1.20), but former heavy smokers had higher risk for both HF (aHR, 1.45; 95% CI, 1.15-1.83) and mortality (aHR, 1.38; 95% CI, 1.17-1.64). However, when compared with current smokers, former heavy smokers had lower risk of death (aHR, 0.64; 95% CI, 0.53-0.77), but not of HF (aHR, 0.97; 95% CI, 0.74-1.28).ConclusionsAfter >15 years of smoking cessation, the risk of HF and death for most former smokers becomes similar to that of never-smokers. Although this benefit of smoking cessation is not extended to those with ≥32 pack-years of prior smoking, they have lower risk of death relative to current smokers.

Published
2015

29. Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Author

Shah, Sanjiv J, Katz, Daniel H, Selvaraj, Senthil, Burke, Michael A, Yancy, Clyde W, Gheorghiade, Mihai, Bonow, Robert O, Huang, Chiang-Ching, and Deo, Rahul C

Subjects
Aging, Cardiovascular, Clinical Research, Heart Disease, Prevention, Aged, Cohort Studies, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Phenotype, Prospective Studies, Stroke Volume, cluster analysis, echocardiography, heart failure, diastolic, patient outcome assessment, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Public Health and Health Services, Cardiovascular System & Hematology
Abstract

BackgroundHeart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome in need of improved phenotypic classification. We sought to evaluate whether unbiased clustering analysis using dense phenotypic data (phenomapping) could identify phenotypically distinct HFpEF categories.Methods and resultsWe prospectively studied 397 patients with HFpEF and performed detailed clinical, laboratory, ECG, and echocardiographic phenotyping of the study participants. We used several statistical learning algorithms, including unbiased hierarchical cluster analysis of phenotypic data (67 continuous variables) and penalized model-based clustering, to define and characterize mutually exclusive groups making up a novel classification of HFpEF. All phenomapping analyses were performed by investigators blinded to clinical outcomes, and Cox regression was used to demonstrate the clinical validity of phenomapping. The mean age was 65±12 years; 62% were female; 39% were black; and comorbidities were common. Although all patients met published criteria for the diagnosis of HFpEF, phenomapping analysis classified study participants into 3 distinct groups that differed markedly in clinical characteristics, cardiac structure/function, invasive hemodynamics, and outcomes (eg, phenogroup 3 had an increased risk of HF hospitalization [hazard ratio, 4.2; 95% confidence interval, 2.0-9.1] even after adjustment for traditional risk factors [P

Published
2015

30. Developing Therapies for Heart Failure With Preserved Ejection Fraction Current State and Future Directions

Author

Butler, Javed, Fonarow, Gregg C, Zile, Michael R, Lam, Carolyn S, Roessig, Lothar, Schelbert, Erik B, Shah, Sanjiv J, Ahmed, Ali, Bonow, Robert O, Cleland, John GF, Cody, Robert J, Chioncel, Ovidiu, Collins, Sean P, Dunnmon, Preston, Filippatos, Gerasimos, Lefkowitz, Martin P, Marti, Catherine N, McMurray, John J, Misselwitz, Frank, Nodari, Savina, O'Connor, Christopher, Pfeffer, Marc A, Pieske, Burkert, Pitt, Bertram, Rosano, Giuseppe, Sabbah, Hani N, Senni, Michele, Solomon, Scott D, Stockbridge, Norman, Teerlink, John R, Georgiopoulou, Vasiliki V, and Gheorghiade, Mihai

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Cardiovascular, Heart Disease, Animals, Clinical Trials as Topic, Diastole, Disease Models, Animal, Echocardiography, Forecasting, Heart Atria, Heart Failure, Humans, Hypertension, Pulmonary, Stroke Volume, Systole, Treatment Outcome, Vascular Stiffness, Ventricular Dysfunction, Left, Ventricular Function, Left, epidemiology, heart failure, preserved ejection fraction, prognosis, treatment, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology
Abstract

The burden of heart failure with preserved ejection fraction (HFpEF) is considerable and is projected to worsen. To date, there are no approved therapies available for reducing mortality or hospitalizations for these patients. The pathophysiology of HFpEF is complex and includes alterations in cardiac structure and function, systemic and pulmonary vascular abnormalities, end-organ involvement, and comorbidities. There remain major gaps in our understanding of HFpEF pathophysiology. To facilitate a discussion of how to proceed effectively in future with development of therapies for HFpEF, a meeting was facilitated by the Food and Drug Administration and included representatives from academia, industry, and regulatory agencies. This document summarizes the proceedings from this meeting.

Published
2014

32. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition

Author

Ajay, Vamadevan S, Afshin, Ashkan, Adler, Alma, Ali, Mohammed K, Bateman, Eric, Bettger, Janet, Bonow, Robert O, Brouwer, Elizabeth, Bukhman, Gene, Bull, Fiona, Burney, Peter, Capewell, Simon, Chan, Juliana, Chandrasekar, Eeshwar K, Chen, Jie, Criqui, Michael H, Dirks, John, Dugani, Sagar B, Engelgau, Michael, El Nahas, Meguid, Fall, Caroline HD, Feigin, Valery, Fowkes, F Gerald R, Glassman, Amanda, Goenka, Shifalika, Gupta, Rajeev, Hasan, Babar, Hersch, Fred, Hu, Frank, Huffman, Mark D, Jabbour, Samer, Jarvis, Deborah, Jeemon, Panniyammakal, Joshi, Rohina, Kamano, Jemima H, Kengne, Andre Pascal, Kudesia, Preeti, Kumar, R Krishna, Kumaran, Kalyanaraman, Lambert, Estelle V, Lee, Edward S, Li, Chaoyun, Luo, Rong, Magee, Matthew, Malik, Vasanti S, Marin-Neto, J Antonio, Marks, Guy, Mayosi, Bongani, McGuire, Helen, Micha, Renata, Miranda, J Jaime, Montoya, Pablo Aschner, Moran, Andrew E, Mozaffarian, Dariush, Naicker, Saraladevi, Naidoo, Nadraj G, Narayan, KM Venkat, Nikolic, Irina, O'Donnell, Martin, Onen, Churchill, Osmond, Clive, Patel, Anushka, Perez-Padilla, Rogelio, Poulter, Neil, Pratt, Michael, Rabkin, Miriam, Rajan, Vikram, Rassi, Anis, Rassi, Anis, Jr, Rawal, Ishita, Remuzzi, Giuseppe, Riella, Miguel, Roth, Greg A, Roy, Ambuj, Rubinstein, Adolfo, Sakuma, Yuna, Sampson, Uchechukwu KA, Siegel, Karen R, Sliwa, Karen, Suhrcke, Marc, Tandon, Nikhil, Thomas, Bernadette, Vaca, Claudia, Vedanthan, Rajesh, Verguet, Stéphane, Webb, Michael, Weber, Mary Beth, Whitsel, Laurie, Wong, Gary, Yan, Lijing L, Yancy, Clyde W, Zhang, Ping, Zhao, Dong, Zhu, Yishan, Prabhakaran, Dorairaj, Anand, Shuchi, Watkins, David, Gaziano, Thomas, Wu, Yangfeng, Mbanya, Jean Claude, and Nugent, Rachel

Published
2018
Full Text
View/download PDF

33. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons

Author

Bonow, Robert O., Brown, Alan S., Gillam, Linda D., Kapadia, Samir R., Kavinsky, Clifford J., Lindman, Brian R., Mack, Michael J., Thourani, Vinod H., Dehmer, Gregory J., Beaver, Thomas M., Bradley, Steven M., Carabello, Blase A., Desai, Milind Y., George, Isaac, Green, Philip, Holmes, David R., Jr, Johnston, Douglas, Leipsic, Jonathon, Mick, Stephanie L., Passeri, Jonathan J., Piana, Robert N., Reichek, Nathaniel, Ruiz, Carlos E., Taub, Cynthia C., Thomas, James D., Turi, Zoltan G., Doherty, John U., Bailey, Steven R., Bhave, Nicole M., Daugherty, Stacie L., Dean, Larry S., Duvernoy, Claire S., Hendel, Robert C., Kramer, Christopher M., Lindsay, Bruce D., Manning, Warren J., Mehrotra, Praveen, Patel, Manesh R., Sachdeva, Ritu, Wann, L. Samuel, Winchester, David E., and Allen, Joseph M.

Published
2018
Full Text
View/download PDF

34. Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction Evidence of Therapeutic Regeneration in the Final 1-Year Results of the CADUCEUS Trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)

Author

Malliaras, Konstantinos, Makkar, Raj R, Smith, Rachel R, Cheng, Ke, Wu, Edwin, Bonow, Robert O, Marbán, Linda, Mendizabal, Adam, Cingolani, Eugenio, Johnston, Peter V, Gerstenblith, Gary, Schuleri, Karl H, Lardo, Albert C, and Marbán, Eduardo

Subjects
Cardiovascular, Heart Disease - Coronary Heart Disease, Transplantation, Clinical Research, Biotechnology, Stem Cell Research, Clinical Trials and Supportive Activities, Regenerative Medicine, Heart Disease, Development of treatments and therapeutic interventions, 5.2 Cellular and gene therapies, Aged, Biopsy, Coronary Vessels, Electrocardiography, Ambulatory, Female, Follow-Up Studies, Heart Ventricles, Humans, Injections, Intra-Arterial, Magnetic Resonance Imaging, Cine, Male, Middle Aged, Myocardial Infarction, Myocytes, Cardiac, Recovery of Function, Stem Cell Transplantation, Time Factors, Transplantation, Autologous, Treatment Outcome, Ventricular Dysfunction, Left, Ventricular Function, Left, cardiosphere-derived cells, myocardial infarction, myocardial regeneration, CDC, CK-MB, CT, DSMB, Data and Safety Monitoring Board, EDV, EF, ESV, Ecc, FWHM, ICD, LV, LVEF, MI, MRI, NYHA, New York Heart Association, SAE, TnI, Vo(2), cardiosphere-derived cell, computed tomography, creatine kinase-myocardial band, ejection fraction, end-diastolic volume, end-systolic volume, full width at half maximum, implantable cardioverter-defibrillator, left ventricular, left ventricular ejection fraction, magnetic resonance imaging, oxygen consumption, serious adverse event(s), systolic circumferential strain, troponin I, Cardiorespiratory Medicine and Haematology, Public Health and Health Services, Cardiovascular System & Hematology
Abstract

ObjectivesThis study sought to report full 1-year results, detailed magnetic resonance imaging analysis, and determinants of efficacy in the prospective, randomized, controlled CADUCEUS (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) trial.BackgroundCardiosphere-derived cells (CDCs) exerted regenerative effects at 6 months in the CADUCEUS trial. Complete results at the final 1-year endpoint are unknown.MethodsAutologous CDCs (12.5 to 25 × 10(6)) grown from endomyocardial biopsy specimens were infused via the intracoronary route in 17 patients with left ventricular dysfunction 1.5 to 3 months after myocardial infarction (MI) (plus 1 infused off-protocol 14 months post-MI). Eight patients were followed as routine-care control patients.ResultsIn 13.4 months of follow-up, safety endpoints were equivalent between groups. At 1 year, magnetic resonance imaging revealed that CDC-treated patients had smaller scar size compared with control patients. Scar mass decreased and viable mass increased in CDC-treated patients but not in control patients. The single patient infused 14 months post-MI responded similarly. CDC therapy led to improved regional function of infarcted segments compared with control patients. Scar shrinkage correlated with an increase in viability and with improvement in regional function. Scar reduction correlated with baseline scar size but not with a history of temporally remote MI or time from MI to infusion. The changes in left ventricular ejection fraction in CDC-treated subjects were consistent with the natural relationship between scar size and ejection fraction post-MI.ConclusionsIntracoronary administration of autologous CDCs did not raise significant safety concerns. Preliminary indications of bioactivity include decreased scar size, increased viable myocardium, and improved regional function of infarcted myocardium at 1 year post-treatment. These results, which are consistent with therapeutic regeneration, merit further investigation in future trials. (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction [CADUCEUS]; NCT00893360).

Published
2014

35. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Author

Otto, Catherine M., Nishimura, Rick A., Bonow, Robert O., Carabello, Blase A., Erwin, John P., III, Gentile, Federico, Jneid, Hani, Krieger, Eric V., Mack, Michael, McLeod, Christopher, O’Gara, Patrick T., Rigolin, Vera H., Sundt, Thoralf M., III, Thompson, Annemarie, and Toly, Christopher

Published
2021
Full Text
View/download PDF

38. JAMA Network Call for Papers on Health and the 2024 US Election

Author

Galbraith, Alison, primary, Flanagin, Annette, additional, Carroll, Aaron E., additional, Ayanian, John Z., additional, Bonow, Robert O., additional, Bressler, Neil, additional, Christakis, Dimitri, additional, Disis, Mary L. (Nora), additional, Inouye, Sharon K., additional, Josephson, Andrew, additional, Öngür, Dost, additional, Piccirillo, Jay F., additional, Shinkai, Kanade, additional, and Bibbins-Domingo, Kirsten, additional

Published
2023
Full Text
View/download PDF

40. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance

Author

Zoghbi, William A., Adams, David, Bonow, Robert O., Enriquez-Sarano, Maurice, Foster, Elyse, Grayburn, Paul A., Hahn, Rebecca T., Han, Yuchi, Hung, Judy, Lang, Roberto M., Little, Stephen H., Shah, Dipan J., Shernan, Stanton, Thavendiranathan, Paaladinesh, Thomas, James D., and Weissman, Neil J.

Published
2017
Full Text
View/download PDF

41. Contributors

Author

Abel, E. Dale, primary, Adamo, Luigi, additional, Ali, Shah R., additional, Allen, Larry A., additional, Bakris, George L., additional, Bloomfield, Gerald S., additional, Bonow, Robert O., additional, Bozkurt, Biykem, additional, Bristow, Michael R., additional, Brown, Angela L., additional, Bugger, Heiko, additional, Burnett, John C., additional, Butler, Javed, additional, Carroll, John D., additional, Castaño, Adam, additional, Chang, Anna Marie, additional, Cohn, Jay N., additional, Colucci, Wilson S., additional, Dell’Italia, Louis J., additional, Deswal, Anita, additional, DeVore, Adam D., additional, Diwan, Abhinav, additional, DuBrock, Hilary M., additional, Dunlay, Shannon M., additional, Dzhoyashvili, Nina, additional, Ewald, Gregory A., additional, Ezekowitz, Justin A., additional, Fang, James C., additional, Fedson, Savitri, additional, Feinstein, Matthew J., additional, Felker, G. Michael, additional, Ferguson, John D., additional, Ferrari, Victor A., additional, Ferrario, Carlos M., additional, Flaherty, James D., additional, Floras, John S., additional, Florea, Viorel G., additional, Gaggin, Hanna K., additional, Greenberg, Barry, additional, Hare, Joshua M., additional, Hernandez, Adrian F., additional, Hill, Joseph A., additional, Ibrahim, Nasrien E., additional, Januzzi, James L., additional, Joseph, Susan M., additional, Judge, Daniel P., additional, Kahn, Andrew M., additional, Kalogeropoulos, Andreas P., additional, Kass, David A., additional, Keaney, John, additional, Khan, Ahsan A., additional, Kim, Paul J., additional, Kobashigawa, Jon A., additional, Kransdorf, Evan P., additional, Krieger, Eric V., additional, Lam, Nicholas T., additional, Lenihan, Daniel J., additional, Lip, Gregory Y.H., additional, Longenecker, Chris T., additional, MacLellan, W. Robb, additional, Mann, Douglas L., additional, Marian, Ali J., additional, Matlock, Daniel D., additional, Maurer, Mathew S., additional, McNamara, Dennis M., additional, Mentz, Robert J., additional, Metra, Marco, additional, Milano, Carmelo A., additional, Misra, Arunima, additional, Mitchell, Joshua D., additional, Morrison, Alan R., additional, Nabeebaccus, Adam, additional, Nakamura, Kenta, additional, Nativi-Nicolau, Jose, additional, Ngo, Doan T.M., additional, Oatmen, Kelsie E., additional, Pang, Peter S., additional, Papadimitriou, Lampros, additional, Paulus, Walter J., additional, Polonsky, Tamar S., additional, Port, J. David, additional, Rader, Florian, additional, Ragupathi, Loheetha, additional, Redfield, Margaret M., additional, Rich, Michael W., additional, Rogers, Joseph G., additional, Ryan, John J., additional, Sadek, Hesham A., additional, Sag, Can Martin, additional, Sapp, Ashley A., additional, Sawyer, Douglas B., additional, Schulze, P. Christian, additional, Shah, Ajay M., additional, Shantsila, Eduard, additional, Singh, Jagmeet P., additional, Sinusas, Albert J., additional, Sliwa, Karen, additional, Spinale, Francis G., additional, Stewart, Simon, additional, Sucharov, Carmen, additional, John Sutton, Martin St., additional, Sverdlov, Aaron L., additional, Toth, Michael J., additional, Valente, Anne Marie, additional, van Heerebeek, Loek, additional, Varagic, Jasmina, additional, Victor, Ronald G., additional, Webb, Ian, additional, Wende, Adam R., additional, Whellan, David, additional, and Wiktor, Dominik M., additional

Published
2020
Full Text
View/download PDF

42. Foreword

Author

Braunwald, Eugene, primary, Zipes, Douglas P., additional, Libby, Peter, additional, Bonow, Robert O., additional, and Tomaselli, Gordon F., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results